HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter A Jones Selected Research

Ascorbic Acid (Vitamin C)

10/2019Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes.
1/2018Vitamin C - A new player in regulation of the cancer epigenome.
1/2016Vitamin C increases viral mimicry induced by 5-aza-2'-deoxycytidine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter A Jones Research Topics

Disease

66Neoplasms (Cancer)
01/2022 - 02/2002
8Carcinogenesis
01/2019 - 10/2005
8Breast Neoplasms (Breast Cancer)
06/2017 - 06/2004
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2013 - 10/2002
7Urinary Bladder Neoplasms (Bladder Cancer)
02/2009 - 02/2002
5Hematologic Neoplasms (Hematological Malignancy)
10/2021 - 06/2009
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2013
4Prostatic Neoplasms (Prostate Cancer)
12/2017 - 10/2006
4Carcinoma (Carcinomatosis)
10/2017 - 04/2002
4Transitional Cell Carcinoma
09/2010 - 10/2005
3Testicular Neoplasms (Testicular Cancer)
01/2019 - 09/2010
3Melanoma (Melanoma, Malignant)
11/2011 - 12/2009
2Colonic Neoplasms (Colon Cancer)
01/2022 - 04/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2021 - 09/2010
2Ascorbic Acid Deficiency (Vitamin C Deficiency)
10/2019 - 01/2016
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Hematologic Diseases (Blood Diseases)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
10/2018
1Endometriosis
10/2017
1Triple Negative Breast Neoplasms
06/2017
1Lymphoma (Lymphomas)
09/2016
1Renal Cell Carcinoma (Grawitz Tumor)
01/2016
1Leukemia
02/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2013
1Inflammation (Inflammations)
07/2013
1Cystitis
07/2013
1Disease Progression
12/2012
1Neoplasm Metastasis (Metastasis)
02/2009
1Adenocarcinoma
12/2008
1Polyps
09/2008

Drug/Important Bio-Agent (IBA)

26DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2002
14ChromatinIBA
10/2017 - 06/2002
13DecitabineFDA Link
10/2021 - 02/2002
12MethyltransferasesIBA
01/2022 - 08/2003
9Histones (Histone)IBA
10/2018 - 11/2002
7Nucleosomes (Nucleosome)IBA
01/2017 - 01/2010
7MicroRNAs (MicroRNA)IBA
04/2011 - 06/2006
6Azacitidine (5 Azacytidine)FDA Link
10/2021 - 09/2010
6Pharmaceutical PreparationsIBA
01/2020 - 07/2007
6pyrimidin-2-one beta-ribofuranosideIBA
09/2008 - 03/2003
5Lysine (L-Lysine)FDA Link
10/2018 - 11/2002
5CytosineIBA
01/2018 - 11/2002
4A-Form DNA (A-DNA)IBA
01/2022 - 04/2015
4AntigensIBA
01/2019 - 08/2004
4Histone Deacetylase InhibitorsIBA
06/2017 - 05/2005
4EnzymesIBA
01/2016 - 05/2004
3Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2019 - 01/2016
3Hormones (Hormone)IBA
06/2017 - 06/2004
3Biological ProductsIBA
09/2011 - 02/2009
2RNA (Ribonucleic Acid)IBA
01/2020 - 09/2010
25-Methylcytosine (5 Methylcytosine)IBA
10/2019 - 01/2011
2entinostat (MS 275)IBA
06/2017 - 05/2017
2Estrogen ReceptorsIBA
06/2017 - 02/2014
2Proteins (Proteins, Gene)FDA Link
02/2014 - 12/2007
2Androgen Receptors (Androgen Receptor)IBA
12/2011 - 10/2006
2MART-1 AntigenIBA
04/2011 - 12/2009
2Polycomb-Group ProteinsIBA
08/2009 - 03/2009
2OligonucleotidesIBA
07/2007 - 02/2002
2Histone Deacetylases (Histone Deacetylase)IBA
06/2006 - 05/2004
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
11/2005 - 11/2002
2Antineoplastic Agents (Antineoplastics)IBA
11/2005 - 01/2005
2polyurethane-polypropylene composite (TMS 1)IBA
11/2005 - 11/2004
1CytidineIBA
10/2021
15-hydroxymethylcytosineIBA
10/2019
1DeoxyguanosineIBA
10/2019
1DNA Transposable Elements (Element, IS)IBA
01/2019
1Antiviral Agents (Antivirals)IBA
10/2018
1Histone MethyltransferasesIBA
10/2018
1PaxillinIBA
10/2017
1IntegrinsIBA
10/2017
1CollagenIBA
10/2017
1Transcription Factors (Transcription Factor)IBA
09/2014
1Genetic Markers (Genetic Marker)IBA
04/2014
1CytokinesIBA
02/2014
1InterferonsIBA
02/2014
1ChemokinesIBA
02/2014
1Estrogens (Estrogen)FDA Link
02/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2013
1Coloring Agents (Dyes)IBA
06/2013
1VorinostatFDA Link
04/2013
1LigandsIBA
12/2011
1trichostatin A (A 300)IBA
04/2011
1SuspensionsIBA
12/2009
13-deazaneplanocinIBA
06/2009
1Polycomb Repressive Complex 2IBA
03/2009
12'-deoxyzebularineIBA
12/2008
1phosphoramidic acidIBA
12/2008
1ProTidesIBA
12/2008
1Aldehyde OxidaseIBA
09/2008

Therapy/Procedure

24Therapeutics
10/2018 - 05/2004
4Aftercare (After-Treatment)
01/2020 - 05/2005
4Drug Therapy (Chemotherapy)
12/2008 - 01/2005
3Oral Administration
09/2008 - 01/2005
2Microbubbles
08/2012 - 02/2011
1Immunotherapy
01/2019
1Investigational Therapies (Experimental Therapy)
11/2013
1Injections
07/2013
1Segmental Mastectomy (Lumpectomy)
06/2013
1Intradermal Injections
02/2011
1Cystectomy
02/2009